The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is the global non-profit NGO representing the research-based pharmaceutical, biotech and vaccine sectors. Its members comprise 27 leading international companies and 44 national and regional industry associations covering developed and developing countries. The industry’s R&D pipeline contains hundreds of new medicines and vaccines being developed to address global disease threats, including cancer, heart disease, HIV/AIDS and malaria. The IFPMA strengthens patient safety by improving risk assessment of medicines and combating their counterfeiting. It also provides the secretariat for the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). PhAMA is affiliated to IFPMA.
The World Self-Medication Industry (WSMI) is a federation of over 50 member associations representing manufacturers and distributors of non-prescription medicines on all continents. We support the development of self-medication industry associations around the world to aid in the understanding and development of responsible self-medication. WSMI requires member associations to develop voluntary codes of advertising practice and encourages consumer-friendly labeling. Companies in the self-medication industry, research, manufacture and distribute non-prescription medicines and dietary supplements, designed and labelled for use without medical supervision. The public is made aware of these health products via direct advertising and they are available in pharmacies and, in many countries around the world, in other outlets. In our role as a Non-Governmental Organization (NGO) in official relations with the World Health Organization, we represent the self-medication industry and contribute to WHO's Public Health goals through our specialized expertise. WSMI also represents the self-medication industry to other international organizations, such as ICH, WIPO, Codex Alimentarius, the World Medical Association, the International Pharmaceutical Federation and the International Council of Nurses. PhAMA is affiliated to IFPMA.
WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. In the 21st century, health is a shared responsibility, involving equitable access to essential care and collective defence against transnational threats.
The Association of the European Self-Medication Industry (AESGP) is the official representation of manufacturers of non-prescription medicines and food supplements in Europe. AESGP was founded in Paris in 1964 to contribute to the improvement of responsible self-medication at the European level and to ensure that the views and interests of the manufacturers of non-prescription medicines and self-care products - including food supplements and self-care medical devices - in Europe are recognised in pharmaceutical and health matters. AESGP is composed of national organisations and several associate members representing primarily the main international companies operating in the area of self-care.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the America’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008. PhRMA's mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical/biotechnology research companies.
The Consumer Healthcare Products Association (CHPA), founded in 1881, is a member-based association representing the leading manufacturers and distributors of nonprescription, over-the-counter (OTC) medicines and nutritional supplements in the United States. Many CHPA member products provide millions of Americans with safe, effective, and convenient therapies for the treatment and prevention of many common ailments and diseases. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and nutritional supplements in America’s healthcare system through science, education, and advocacy. The association provides leadership and guidance on regulatory and scientific issues to Congress; state legislatures; and federal, state, and international government agencies.
Medicines Australia represents the innovative medicines industry in Australia. Our member companies comprise more than 80 percent of the prescription pharmaceuticals market, and are engaged in the research, development, manufacture, supply and export of prescription medicines. Medicines save lives, reduce and cure disease. Medicines Australia is committed to enhancing the health of Australians by providing access to medicines of the highest quality, safety and efficacy.
"Better health through responsible self-care". ASMI (Australian Self Medication Industry) is the peak body representing companies involved in the manufacture and distribution of consumer healthcare products in Australia. Since its establishment in 1974, the Association has focussed its efforts on supporting the progress and development of the Self Care products industry, including both OTCs and complementary products.
The World Trade Organization (WTO) is the only global international organization dealing with the rules of trade between nations. Its main function is to ensure that trade flows as smoothly, predictably and freely as possible. At its heart are the WTO agreements, negotiated and signed by the bulk of the world’s trading nations and ratified in their parliaments. The goal is to help producers of goods and services, exporters, and importers conduct their business.
The Pharmaceutical Trade Association (PTA) was founded on 26 May 1966. On 19 December 1975, the Association's name was changed to the Singapore Association of Pharmaceutical Industries (SAPI) so as to encompass a wider spectrum of pharmaceutical related businesses into the Association, namely the trading houses, manufacturers, representative offices and pharmacies. As a body, SAPI supports legislation that seeks to improve the pharmaceutical trade in Singapore; represents its members to the Government on issues regarding laws/regulations that pertain to the pharmaceutical industry; assists members in solving their problems in the industry like parallel imports, counterfeit products and patent infringements; promotes ethical practices in order to improve the image and credibility of the industry and SAPI members through the voluntary acceptance and adherence to the SAPI Code of Marketing Practices; undertakes surveys which are of service to its members; upgrades professional skills of medical representatives and staff of member companies by organising relevant training courses; and promotes goodwill, common understanding, close collaboration and rapport with the various medical and allied professional bodies.